Breast Cancer:@0.781548:0.035749:0.914554:0.035749:0.914554:0.019993:0.781548:0.019993:0.011045:0.005717:0.012508:0.013143:0.007466:0.006523:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
45:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Dr K Tabane:@0.084848:0.151374:0.197224:0.151374:0.197224:0.135340:0.084848:0.135340:0.013470:0.006158:0.005388:0.011930:0.005388:0.008082:0.012700:0.012700:0.012700:0.011545:0.012315
MBChB,FCP(SA); Certificate of Medical :@0.084848:0.167725:0.448530:0.167725:0.448530:0.151506:0.084848:0.151506:0.017318:0.011161:0.015009:0.011545:0.011161:0.005388:0.009236:0.015009:0.010776:0.007312:0.010006:0.014239:0.007312:0.005388:0.005388:0.015009:0.012315:0.006158:0.005773:0.004618:0.005003:0.005003:0.012315:0.012700:0.005773:0.012315:0.005388:0.012315:0.005388:0.005388:0.017318:0.012315:0.012700:0.004618:0.012315:0.012700:0.004618:0.005388
Oncology (Physicians):@0.084848:0.184076:0.294206:0.184076:0.294206:0.167858:0.084848:0.167858:0.016164:0.011545:0.012315:0.012315:0.004618:0.012315:0.012700:0.011161:0.005388:0.007312:0.010776:0.011545:0.011161:0.008467:0.004618:0.012315:0.004618:0.012700:0.011545:0.008467:0.007312
 :@0.084848:0.200309:0.121236:0.200309:0.121236:0.185624:0.084848:0.185624:0.017145:0.019242
Specialist Physician, Medical :@0.121236:0.200428:0.391495:0.200428:0.391495:0.184672:0.121236:0.184672:0.009583:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.006523:0.005330:0.011392:0.011738:0.010314:0.007466:0.003848:0.012450:0.003848:0.013143:0.011738:0.005330:0.005330:0.017684:0.012508:0.013181:0.003848:0.012450:0.013143:0.003848:0.005330
Oncologist, Director: Sandton Oncology:@0.084848:0.216779:0.457743:0.216779:0.457743:0.201023:0.084848:0.201023:0.016722:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.005330:0.005330:0.014316:0.003848:0.005711:0.012508:0.012450:0.006523:0.012604:0.005792:0.005330:0.005330:0.009583:0.013143:0.011738:0.013181:0.006523:0.012604:0.011738:0.005330:0.016722:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.010314
According to the CANSA statistics, breast :@0.084848:0.249481:0.481090:0.249481:0.481090:0.233726:0.084848:0.233726:0.014239:0.012450:0.012450:0.012604:0.005665:0.013181:0.003848:0.011738:0.012950:0.006985:0.006523:0.012604:0.006972:0.006523:0.011738:0.012508:0.006973:0.015644:0.014239:0.014239:0.009583:0.014239:0.006966:0.007466:0.006523:0.013143:0.006523:0.003848:0.007466:0.006523:0.003848:0.012450:0.007466:0.005330:0.006985:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.005330
cancer  is the  most  common cancer  af-:@0.084848:0.265833:0.475765:0.265833:0.475765:0.250077:0.084848:0.250077:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.004160:0.003848:0.007466:0.009506:0.006523:0.011738:0.012508:0.005330:0.004160:0.018049:0.012604:0.007466:0.006523:0.005330:0.004164:0.012450:0.012604:0.018049:0.018049:0.012604:0.011726:0.009506:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.004160:0.013143:0.006042:0.006388
fecting South African women.:@0.084848:0.282184:0.362516:0.282184:0.362516:0.266428:0.084848:0.266428:0.006042:0.012508:0.012450:0.006523:0.003848:0.011738:0.012950:0.005330:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.011738:0.005330:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330
Unfortunately,  the  national registry  has :@0.103032:0.298535:0.481092:0.298535:0.481092:0.282779:0.103032:0.282779:0.012604:0.011738:0.006042:0.012604:0.005792:0.006523:0.011699:0.011738:0.013143:0.006523:0.012508:0.003848:0.010314:0.005330:0.005330:0.004031:0.006523:0.011738:0.012508:0.005330:0.004047:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.009390:0.005713:0.012508:0.012950:0.003848:0.007466:0.006523:0.005792:0.010314:0.005330:0.004051:0.011738:0.013143:0.007466:0.005330
been fraught with challenges, and this has :@0.084848:0.314886:0.481105:0.314886:0.481105:0.299131:0.084848:0.299131:0.013123:0.012508:0.012508:0.011738:0.004587:0.006042:0.005792:0.013143:0.011699:0.012950:0.011738:0.006523:0.004580:0.015990:0.003848:0.006523:0.011738:0.004589:0.012450:0.011738:0.013143:0.003848:0.003848:0.012508:0.011738:0.012950:0.012508:0.007466:0.005330:0.004599:0.013143:0.011738:0.013181:0.004599:0.006523:0.011738:0.003848:0.007466:0.004599:0.011738:0.013143:0.007466:0.005330
hindered accurate assessment of the bur-:@0.084848:0.331238:0.475750:0.331238:0.475750:0.315482:0.084848:0.315482:0.011738:0.003848:0.011738:0.013181:0.012508:0.005711:0.012508:0.013181:0.005609:0.013143:0.012450:0.012450:0.011699:0.005792:0.013143:0.006523:0.012508:0.005603:0.013143:0.007466:0.007466:0.012508:0.007466:0.007466:0.018049:0.012508:0.011738:0.006523:0.005609:0.012604:0.006042:0.005607:0.006523:0.011738:0.012508:0.005603:0.013123:0.011699:0.005792:0.006388
den of disease. This is currently in the pro-:@0.084848:0.347589:0.475731:0.347589:0.475731:0.331833:0.084848:0.331833:0.013181:0.012508:0.011738:0.006504:0.012604:0.006042:0.006504:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.006504:0.008197:0.011738:0.003848:0.007466:0.006504:0.003848:0.007466:0.006504:0.012450:0.011699:0.005792:0.005707:0.012508:0.011738:0.006523:0.003848:0.010314:0.006504:0.003848:0.011738:0.006504:0.006523:0.011738:0.012508:0.006504:0.013123:0.005715:0.012604:0.006388
cess of being updated with NHLS and the :@0.084848:0.363940:0.481109:0.363940:0.481109:0.348184:0.084848:0.348184:0.012450:0.012508:0.007466:0.007466:0.006023:0.012604:0.006042:0.006006:0.013123:0.012508:0.003848:0.011738:0.012950:0.006009:0.011699:0.013123:0.013181:0.013143:0.006523:0.012508:0.013181:0.006011:0.015990:0.003848:0.006523:0.011738:0.006011:0.014239:0.013143:0.008890:0.009583:0.006013:0.013143:0.011738:0.013181:0.006011:0.006523:0.011738:0.012508:0.005330
Department of Health.:@0.084848:0.380291:0.294610:0.380291:0.294610:0.364536:0.084848:0.364536:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.013143:0.012508:0.013143:0.003848:0.006523:0.011738:0.005330
South Africa is among the most unequal :@0.103032:0.396643:0.481099:0.396643:0.481099:0.380887:0.103032:0.380887:0.009583:0.012604:0.011699:0.006523:0.011738:0.005349:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005349:0.003848:0.007466:0.005361:0.013143:0.018049:0.012604:0.011738:0.012950:0.005349:0.006523:0.011738:0.012508:0.005349:0.018049:0.012604:0.007466:0.006523:0.005349:0.011699:0.011738:0.012508:0.013123:0.011699:0.013143:0.003848:0.005330
societies in the world. This is apparent in :@0.084848:0.412994:0.481096:0.412994:0.481096:0.397238:0.084848:0.397238:0.007466:0.012604:0.012450:0.003848:0.012508:0.006523:0.003848:0.012508:0.007466:0.008775:0.003848:0.011738:0.008775:0.006523:0.011738:0.012508:0.008775:0.015990:0.012604:0.005792:0.003848:0.013181:0.005330:0.008775:0.008197:0.011738:0.003848:0.007466:0.008775:0.003848:0.007466:0.008775:0.013143:0.013123:0.013123:0.013143:0.005723:0.012508:0.011738:0.006523:0.008775:0.003848:0.011738:0.005330
the disparate care of patients in the pri-:@0.084848:0.429345:0.475775:0.429345:0.475775:0.413589:0.084848:0.413589:0.006523:0.011738:0.012508:0.008370:0.013181:0.003848:0.007466:0.013123:0.013143:0.005792:0.013143:0.006523:0.012508:0.008370:0.012450:0.013143:0.005713:0.012508:0.008370:0.012604:0.006042:0.008370:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008370:0.003848:0.011738:0.008370:0.006523:0.011738:0.012508:0.008370:0.013123:0.005792:0.003848:0.006388
vate sector compared to those in the pub-:@0.084848:0.445696:0.475781:0.445696:0.475781:0.429941:0.084848:0.429941:0.010660:0.013143:0.006523:0.012508:0.004195:0.007466:0.012508:0.012450:0.006523:0.012604:0.005792:0.004179:0.012450:0.012604:0.018049:0.013123:0.013143:0.005717:0.012508:0.013181:0.004195:0.006523:0.012604:0.004185:0.006523:0.011738:0.012604:0.007466:0.012508:0.004195:0.003848:0.011738:0.004195:0.006523:0.011738:0.012508:0.004183:0.013123:0.011699:0.013123:0.006388
lic sector. Breast cancer is unfortunately :@0.084848:0.462048:0.481098:0.462048:0.481098:0.446292:0.084848:0.446292:0.003848:0.003848:0.012450:0.009910:0.007466:0.012508:0.012450:0.006523:0.012604:0.004376:0.005330:0.009910:0.011045:0.005717:0.012508:0.013143:0.007466:0.006523:0.009910:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.009910:0.003848:0.007466:0.009910:0.011699:0.011738:0.006042:0.012604:0.005792:0.006523:0.011699:0.011738:0.013143:0.006523:0.012508:0.003848:0.010314:0.005330
no  different,  with the  majority of  women :@0.084848:0.478399:0.481113:0.478399:0.481113:0.462643:0.084848:0.462643:0.011738:0.012604:0.005330:0.003085:0.013181:0.003848:0.006104:0.006042:0.012508:0.005713:0.012508:0.011738:0.006523:0.005330:0.005330:0.003083:0.015990:0.003848:0.006523:0.011738:0.008428:0.006523:0.011738:0.012508:0.005330:0.003085:0.018049:0.013143:0.003906:0.012604:0.005792:0.003848:0.006523:0.010314:0.008428:0.012604:0.006042:0.005330:0.003086:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330
in the private sector presenting with early :@0.084848:0.494750:0.481098:0.494750:0.481098:0.478994:0.084848:0.478994:0.003848:0.011738:0.006639:0.006523:0.011738:0.012508:0.006627:0.013123:0.005792:0.003848:0.010660:0.013143:0.006523:0.012508:0.006639:0.007466:0.012508:0.012450:0.006523:0.012604:0.005792:0.006621:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.006639:0.015990:0.003848:0.006523:0.011738:0.006639:0.012508:0.013143:0.005792:0.003848:0.010314:0.005330
stage breast cancer, where the treatment :@0.084848:0.511101:0.481103:0.511101:0.481103:0.495346:0.084848:0.495346:0.007466:0.006523:0.013143:0.012950:0.012508:0.005205:0.013123:0.005713:0.012508:0.013143:0.007466:0.006523:0.005215:0.012450:0.013143:0.011738:0.012450:0.012508:0.003762:0.005330:0.005205:0.015990:0.011738:0.012508:0.005709:0.012508:0.005205:0.006523:0.011738:0.012508:0.005205:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
intent is usually curative, compared to the :@0.084848:0.527453:0.481109:0.527453:0.481109:0.511697:0.084848:0.511697:0.003848:0.011738:0.006523:0.012508:0.011738:0.006523:0.005340:0.003848:0.007466:0.005349:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010325:0.005349:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.005349:0.012450:0.012604:0.018049:0.013123:0.013143:0.005715:0.012508:0.013181:0.005349:0.006523:0.012604:0.005349:0.006523:0.011738:0.012508:0.005330
public sector, where women present with :@0.084848:0.543804:0.481088:0.543804:0.481088:0.528048:0.084848:0.528048:0.013123:0.011699:0.013123:0.003848:0.003848:0.012450:0.007043:0.007466:0.012508:0.012450:0.006523:0.012604:0.003762:0.005330:0.007029:0.015990:0.011738:0.012508:0.005707:0.012508:0.007031:0.015990:0.012604:0.018049:0.012508:0.011738:0.007023:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007027:0.015990:0.003848:0.006523:0.011738:0.005330
advanced stage disease, with subsequent :@0.084848:0.560155:0.481098:0.560155:0.481098:0.544399:0.084848:0.544399:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.004233:0.007466:0.006523:0.013143:0.012950:0.012508:0.004224:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.004233:0.015990:0.003848:0.006523:0.011738:0.004233:0.007466:0.011699:0.013123:0.007466:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.005330
poorer outcomes, against the backdrop :@0.084848:0.576506:0.481107:0.576506:0.481107:0.560751:0.084848:0.560751:0.013123:0.012604:0.012604:0.005707:0.012508:0.005792:0.009198:0.012604:0.011699:0.006523:0.012450:0.012604:0.018036:0.012508:0.007466:0.005330:0.009198:0.013143:0.012950:0.013143:0.003848:0.011738:0.007466:0.006523:0.009198:0.006523:0.011738:0.012508:0.009198:0.013123:0.013143:0.012450:0.009660:0.013181:0.005717:0.012604:0.013123:0.005330
of limited resources.:@0.084848:0.592858:0.269354:0.592858:0.269354:0.577102:0.084848:0.577102:0.012604:0.006042:0.005330:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.005330:0.005709:0.012508:0.007466:0.012604:0.011699:0.005653:0.012450:0.012508:0.007466:0.005330
The  most common  presentation  of :@0.103032:0.609209:0.481107:0.609209:0.481107:0.593453:0.103032:0.593453:0.008197:0.011738:0.012508:0.005330:0.013187:0.018049:0.012604:0.007466:0.006523:0.018530:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.013189:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.013187:0.012604:0.006042:0.005330
breast  cancer  is  the  finding  of  a  breast :@0.084848:0.625560:0.481086:0.625560:0.481086:0.609804:0.084848:0.609804:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.005330:0.004555:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.004547:0.003848:0.007466:0.005330:0.004562:0.006523:0.011738:0.012508:0.005330:0.004547:0.004686:0.004686:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330:0.004547:0.012604:0.006042:0.005330:0.004549:0.013143:0.005330:0.004557:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.005330
lump, or axillary lymphadenopathy. Oth-:@0.084848:0.641911:0.475750:0.641911:0.475750:0.626156:0.084848:0.626156:0.003848:0.011699:0.018049:0.013123:0.005330:0.008871:0.012604:0.005792:0.008871:0.013143:0.009236:0.003848:0.003848:0.003848:0.013143:0.005804:0.010314:0.008871:0.003848:0.010314:0.018049:0.013123:0.011738:0.013143:0.013181:0.012508:0.011738:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.005330:0.008871:0.016722:0.006523:0.011738:0.006388
er symptoms may include thickened skin :@0.084848:0.658263:0.481088:0.658263:0.481088:0.642507:0.084848:0.642507:0.012508:0.005792:0.008274:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.008274:0.018049:0.013143:0.010314:0.008274:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.008274:0.006523:0.011738:0.003848:0.012450:0.009660:0.012508:0.011738:0.012508:0.013181:0.008274:0.007466:0.009660:0.003848:0.011738:0.005330
with an orange-peel appearance (:@0.084848:0.674614:0.425277:0.674614:0.425277:0.658858:0.084848:0.658858:0.015990:0.003848:0.006523:0.011738:0.008145:0.013143:0.011738:0.008145:0.012604:0.005792:0.013143:0.011738:0.012950:0.012494:0.006388:0.013123:0.012508:0.012508:0.003848:0.008149:0.013143:0.013123:0.013123:0.012508:0.013143:0.005792:0.013143:0.011738:0.012450:0.012508:0.008143:0.007100
peau :@0.425277:0.674614:0.481080:0.674614:0.481080:0.658858:0.425277:0.658858:0.013123:0.012508:0.013143:0.011699:0.005330
d’orange:@0.084848:0.690965:0.173517:0.690965:0.173517:0.675209:0.084848:0.675209:0.013181:0.006754:0.012604:0.005792:0.013143:0.011738:0.012950:0.012508
), an enlarged node at the base :@0.173498:0.690965:0.481086:0.690965:0.481086:0.675209:0.173498:0.675209:0.007100:0.005330:0.005426:0.013143:0.011738:0.005426:0.012508:0.011738:0.003848:0.013143:0.005809:0.012950:0.012508:0.013181:0.005426:0.011738:0.012604:0.013181:0.012508:0.005426:0.013143:0.006523:0.005426:0.006523:0.011738:0.012508:0.005426:0.013123:0.013143:0.007466:0.012508:0.005330
of the neck, a bloody nipple discharge, or :@0.084848:0.707316:0.481082:0.707316:0.481082:0.691561:0.084848:0.691561:0.012604:0.006042:0.005138:0.006523:0.011738:0.012508:0.005138:0.011738:0.012508:0.012450:0.009660:0.005330:0.005138:0.013143:0.005138:0.013123:0.003848:0.012604:0.012604:0.013181:0.010314:0.005138:0.011738:0.003848:0.013123:0.013123:0.003848:0.012508:0.005151:0.013181:0.003848:0.007466:0.012450:0.011738:0.013143:0.005811:0.012950:0.012508:0.005330:0.005138:0.012604:0.005792:0.005330
ulceration  of  the breast and surrounding :@0.084848:0.723668:0.481117:0.723668:0.481117:0.707912:0.084848:0.707912:0.011699:0.003848:0.012450:0.012508:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.003142:0.012604:0.006042:0.005330:0.003146:0.006523:0.011738:0.012508:0.008486:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.008486:0.013143:0.011738:0.013181:0.008486:0.007466:0.011699:0.005792:0.005709:0.012604:0.011699:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330
tissues.:@0.084848:0.740019:0.147155:0.740019:0.147155:0.724263:0.084848:0.724263:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.005330
The risk of breast cancer increases with :@0.103032:0.756370:0.481092:0.756370:0.481092:0.740614:0.103032:0.740614:0.008197:0.011738:0.012508:0.007224:0.005792:0.003848:0.007466:0.009660:0.007235:0.012604:0.006042:0.007226:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.007235:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007224:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.007466:0.007235:0.015990:0.003848:0.006523:0.011738:0.005330
age. However, increasingly  younger  pa-:@0.084848:0.772721:0.475752:0.772721:0.475752:0.756966:0.084848:0.756966:0.013143:0.012950:0.012508:0.005330:0.010160:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003770:0.005330:0.010160:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.003848:0.011738:0.012950:0.003848:0.010314:0.005330:0.004841:0.010314:0.012604:0.011699:0.011738:0.012950:0.012508:0.005792:0.005330:0.004816:0.013123:0.013143:0.006388
tients are being diagnosed. Only 10-15% :@0.084848:0.789073:0.481084:0.789073:0.481084:0.773317:0.084848:0.773317:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008852:0.013143:0.005711:0.012508:0.008852:0.013123:0.012508:0.003848:0.011738:0.012950:0.008852:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330:0.008852:0.016722:0.011738:0.003848:0.010314:0.008852:0.010660:0.010660:0.006388:0.010660:0.010660:0.014913:0.005330
of breast cancers are as a result of a ge-:@0.084848:0.805424:0.475779:0.805424:0.475779:0.789668:0.084848:0.789668:0.012604:0.006042:0.006854:0.013123:0.005717:0.012508:0.013143:0.007466:0.006523:0.006860:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.006856:0.013143:0.005715:0.012508:0.006858:0.013143:0.007466:0.006870:0.013143:0.006870:0.005711:0.012508:0.007466:0.011699:0.003848:0.006523:0.006870:0.012604:0.006042:0.006856:0.013143:0.006860:0.012950:0.012508:0.006388
netic aberration, meaning that the major-:@0.084848:0.821775:0.475787:0.821775:0.475787:0.806019:0.084848:0.806019:0.011738:0.012508:0.006523:0.003848:0.012450:0.005561:0.013143:0.013123:0.012508:0.005792:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005544:0.018049:0.012508:0.013143:0.011738:0.003848:0.011738:0.012950:0.005561:0.006523:0.011738:0.013143:0.006523:0.005561:0.006523:0.011738:0.012508:0.005550:0.018049:0.013143:0.003906:0.012604:0.005792:0.006388
ity of breast cancers are sporadic.:@0.084848:0.838126:0.403141:0.838126:0.403141:0.822371:0.084848:0.822371:0.003848:0.006523:0.010314:0.005330:0.012604:0.006042:0.005330:0.013123:0.005709:0.012508:0.013143:0.007466:0.006523:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.013143:0.005705:0.012508:0.005330:0.007466:0.013123:0.012604:0.005792:0.013143:0.013181:0.003848:0.012450:0.005330
1:@0.403137:0.832516:0.409352:0.832516:0.409352:0.823330:0.403137:0.823330:0.006215
The  diagnosis is made on  a mammo-:@0.103030:0.854487:0.475765:0.854487:0.475765:0.838731:0.103030:0.838731:0.008197:0.011738:0.012508:0.005330:0.005007:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.010352:0.003848:0.007466:0.010352:0.018049:0.013143:0.013181:0.012508:0.010352:0.012604:0.011738:0.005330:0.005009:0.013143:0.010352:0.018049:0.013143:0.018049:0.018049:0.012604:0.006388
gram combined with a breast ultrasound. :@0.084846:0.870838:0.481107:0.870838:0.481107:0.855082:0.084846:0.855082:0.012950:0.005792:0.013143:0.018049:0.006144:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.012508:0.013181:0.006146:0.015990:0.003848:0.006523:0.011738:0.006148:0.013143:0.006158:0.013123:0.005713:0.012508:0.013143:0.007466:0.006523:0.006158:0.011699:0.003848:0.006523:0.005792:0.013143:0.007466:0.012604:0.011699:0.011738:0.013181:0.005330:0.005330
A core biopsy  of the breast mass,  rather :@0.084846:0.887189:0.481088:0.887189:0.481088:0.871433:0.084846:0.871433:0.014239:0.008293:0.012450:0.012604:0.005709:0.012508:0.008293:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.005330:0.002979:0.012604:0.006042:0.008293:0.006523:0.011738:0.012508:0.008293:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.008293:0.018049:0.013143:0.007466:0.007466:0.005330:0.005330:0.002975:0.005792:0.013143:0.006523:0.011738:0.012508:0.005792:0.005330
than a fine-needle aspiration (FNA) is pre-:@0.084846:0.903540:0.475756:0.903540:0.475756:0.887784:0.084846:0.887784:0.006523:0.011738:0.013143:0.011738:0.006004:0.013143:0.006009:0.004686:0.004686:0.011738:0.012508:0.006388:0.011738:0.012508:0.012494:0.013181:0.003848:0.012508:0.006011:0.013143:0.007466:0.013123:0.003848:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.006013:0.007100:0.009333:0.014239:0.014239:0.007100:0.006002:0.003848:0.007466:0.006015:0.013123:0.005715:0.012508:0.006388
ferred. Core biopsy allows for  more ac-:@0.084846:0.919892:0.475763:0.919892:0.475763:0.904136:0.084846:0.904136:0.006042:0.012508:0.005792:0.005705:0.012508:0.013181:0.005330:0.010122:0.015644:0.012604:0.005709:0.012508:0.010122:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.010122:0.013143:0.003848:0.003848:0.012604:0.015990:0.007466:0.010122:0.006042:0.012604:0.005792:0.005330:0.004782:0.018049:0.012604:0.005709:0.012508:0.010122:0.013143:0.012450:0.006388
curate assessment  of the biology of the :@0.084846:0.936243:0.481097:0.936243:0.481097:0.920487:0.084846:0.920487:0.012450:0.011699:0.005792:0.013143:0.006523:0.012508:0.009390:0.013143:0.007466:0.007466:0.012508:0.007466:0.007466:0.018049:0.012508:0.011738:0.006523:0.005330:0.004072:0.012604:0.006042:0.009390:0.006523:0.011738:0.012508:0.009390:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.009390:0.012604:0.006042:0.009390:0.006523:0.011738:0.012508:0.005330
cancer, which is important in determining :@0.524246:0.151370:0.920494:0.151370:0.920494:0.135614:0.524246:0.135614:0.012450:0.013143:0.011738:0.012450:0.012508:0.003764:0.005330:0.006465:0.015990:0.011738:0.003848:0.012450:0.011738:0.006465:0.003848:0.007466:0.006465:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.006454:0.003848:0.011738:0.006465:0.013181:0.012508:0.006523:0.012508:0.006319:0.018049:0.003848:0.011738:0.003848:0.011738:0.012950:0.005330
the treatment approach.:@0.524246:0.167602:0.759250:0.167602:0.759250:0.151846:0.524246:0.151846:0.006523:0.011738:0.012508:0.005330:0.006523:0.005700:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.013143:0.013123:0.013123:0.005707:0.012604:0.013143:0.012450:0.011738:0.005330
STAGING:@0.524242:0.200708:0.627253:0.200708:0.627253:0.181111:0.524242:0.181111:0.012230:0.009878:0.017404:0.019756:0.006585:0.017404:0.019756
Breast cancer is staged according to the :@0.524242:0.219230:0.920499:0.219230:0.920499:0.203474:0.524242:0.203474:0.011045:0.005717:0.012508:0.013143:0.007466:0.006523:0.006908:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006898:0.003848:0.007466:0.006908:0.007466:0.006523:0.013143:0.012950:0.012508:0.013181:0.006908:0.013143:0.012450:0.012450:0.012604:0.005675:0.013181:0.003848:0.011738:0.012950:0.006908:0.006523:0.012604:0.006896:0.006523:0.011738:0.012508:0.005330
TNM criteria, which takes into account :@0.524242:0.235462:0.920501:0.235462:0.920501:0.219706:0.524242:0.219706:0.008197:0.014239:0.017684:0.012238:0.012450:0.005792:0.003848:0.006523:0.012508:0.005792:0.003848:0.013143:0.005330:0.012238:0.015990:0.011738:0.003848:0.012450:0.011738:0.012238:0.006523:0.013143:0.009660:0.012508:0.007466:0.012238:0.003848:0.011738:0.006523:0.012604:0.012238:0.013143:0.012450:0.012450:0.012604:0.011699:0.011738:0.006523:0.005330
tumour  size,  locoregional  nodal involve-:@0.524242:0.251694:0.915153:0.251694:0.915153:0.235938:0.524242:0.235938:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.005305:0.007466:0.003848:0.008178:0.012508:0.005330:0.005330:0.005319:0.003848:0.012604:0.012450:0.012604:0.005709:0.012508:0.012950:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.005317:0.011738:0.012604:0.013181:0.013143:0.003848:0.010660:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.006388
ment,  and  the  presence  or  absence  of :@0.524242:0.267926:0.920491:0.267926:0.920491:0.252170:0.524242:0.252170:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330:0.004655:0.013143:0.011738:0.013181:0.005330:0.004664:0.006523:0.011738:0.012508:0.005330:0.004666:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.005330:0.004661:0.012604:0.005792:0.005330:0.004657:0.013143:0.013123:0.007466:0.012508:0.011738:0.012450:0.012508:0.005330:0.004666:0.012604:0.006042:0.005330
distant metastasis (see Table 1).:@0.524242:0.284158:0.816619:0.284158:0.816619:0.268402:0.524242:0.268402:0.013181:0.003848:0.007466:0.006523:0.013143:0.011738:0.006523:0.005330:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330:0.007100:0.007466:0.012508:0.012508:0.005330:0.007204:0.013143:0.013123:0.003848:0.012508:0.005330:0.010660:0.007100:0.005330
By definition, early breast cancer is can-:@0.542426:0.300391:0.915153:0.300391:0.915153:0.284635:0.542426:0.284635:0.011045:0.010314:0.005588:0.013181:0.012508:0.004686:0.004686:0.011738:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.005569:0.012508:0.013143:0.005792:0.003848:0.010314:0.005584:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.005582:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005573:0.003848:0.007466:0.005588:0.012450:0.013143:0.011738:0.006388
cer that is limited to the breast and/or ax-:@0.524242:0.316623:0.915149:0.316623:0.915149:0.300867:0.524242:0.300867:0.012450:0.012508:0.005792:0.005888:0.006523:0.011738:0.013143:0.006523:0.005888:0.003848:0.007466:0.005888:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.005888:0.006523:0.012604:0.005888:0.006523:0.011738:0.012508:0.005888:0.013123:0.005713:0.012508:0.013143:0.007466:0.006523:0.005888:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005888:0.013143:0.009236:0.006388
illa. However, a tumour in excess of 5 cm, :@0.524242:0.332855:0.920462:0.332855:0.920462:0.317099:0.524242:0.317099:0.003848:0.003848:0.003848:0.013143:0.005330:0.006575:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003768:0.005330:0.006562:0.013143:0.006562:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006552:0.003848:0.011738:0.006562:0.012508:0.009236:0.012450:0.012508:0.007466:0.007466:0.006562:0.012604:0.006042:0.006562:0.010660:0.006562:0.012450:0.018049:0.005330:0.005330
involvement of multiple locoregional :@0.524242:0.349087:0.920470:0.349087:0.920470:0.333331:0.524242:0.333331:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.018049:0.012508:0.011738:0.006523:0.022090:0.012604:0.006042:0.022090:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.022090:0.003848:0.012604:0.012450:0.012604:0.005703:0.012508:0.012950:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330
lymph nodes,  skin changes  and/or  inva-:@0.524242:0.365319:0.915149:0.365319:0.915149:0.349563:0.524242:0.349563:0.003848:0.010314:0.018049:0.013123:0.011738:0.009140:0.011738:0.012604:0.013181:0.012508:0.007466:0.005330:0.005330:0.003797:0.007466:0.009660:0.003848:0.011738:0.009140:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466:0.005330:0.003798:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330:0.003795:0.003848:0.011738:0.010660:0.013143:0.006388
sion of the chest wall imply the diagnosis :@0.524242:0.381551:0.920493:0.381551:0.920493:0.365796:0.524242:0.365796:0.007466:0.003848:0.012604:0.011738:0.007447:0.012604:0.006042:0.007447:0.006523:0.011738:0.012508:0.007447:0.012450:0.011738:0.012508:0.007466:0.006523:0.007447:0.015990:0.013143:0.003848:0.003848:0.007447:0.003848:0.018049:0.013123:0.003848:0.010314:0.007458:0.006523:0.011738:0.012508:0.007447:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330
of locally advanced breast cancer.:@0.524242:0.397784:0.854738:0.397784:0.854738:0.382028:0.524242:0.382028:0.012604:0.006042:0.005330:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330:0.013123:0.005719:0.012508:0.013143:0.007466:0.006523:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.004372:0.005330
TUMOUR BIOLOGY:@0.524242:0.430853:0.729793:0.430853:0.729793:0.411256:0.524242:0.411256:0.009878:0.015052:0.021167:0.019756:0.015052:0.013641:0.006585:0.013641:0.006585:0.019756:0.010348:0.019756:0.019756:0.014581
In broad terms, breast cancer biology is :@0.524242:0.449375:0.920470:0.449375:0.920470:0.433619:0.524242:0.433619:0.004349:0.011738:0.008948:0.013123:0.005715:0.012604:0.013143:0.013181:0.008948:0.006523:0.012508:0.006319:0.018049:0.007466:0.005330:0.008948:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.008948:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.008948:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.008948:0.003848:0.007466:0.005330
divided into :@0.524242:0.465607:0.644468:0.465607:0.644468:0.449851:0.524242:0.449851:0.013181:0.003848:0.010660:0.003848:0.013181:0.012508:0.013181:0.009775:0.003848:0.011738:0.006523:0.012604:0.005330
favourable vs unfavourable :@0.648913:0.465607:0.920481:0.465607:0.920481:0.449851:0.648913:0.449851:0.006042:0.013143:0.010660:0.012604:0.011699:0.005792:0.013143:0.013123:0.003848:0.012508:0.009775:0.010660:0.007466:0.009775:0.011699:0.011738:0.006042:0.013143:0.010660:0.012604:0.011699:0.005792:0.013143:0.013123:0.003848:0.012508:0.005330
biology.:@0.524242:0.481839:0.598864:0.481839:0.598864:0.466083:0.524242:0.466083:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330
 The surrogate for this is the IHC 4 :@0.598864:0.481839:0.920476:0.481839:0.920476:0.466083:0.598864:0.466083:0.006947:0.008197:0.011738:0.012508:0.006937:0.007466:0.011699:0.005792:0.005709:0.012604:0.012950:0.013143:0.006523:0.012508:0.006937:0.006042:0.012604:0.005792:0.006947:0.006523:0.011738:0.003848:0.007466:0.006947:0.003848:0.007466:0.006947:0.006523:0.011738:0.012508:0.006947:0.004349:0.013143:0.015644:0.006947:0.010660:0.005330
test, which includes assessment of oestro-:@0.524242:0.498071:0.915178:0.498071:0.915178:0.482316:0.524242:0.482316:0.006523:0.012508:0.007466:0.006523:0.005330:0.006658:0.015990:0.011738:0.003848:0.012450:0.011738:0.006658:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007466:0.006658:0.013143:0.007466:0.007466:0.012508:0.007466:0.007466:0.018049:0.012521:0.011738:0.006523:0.006658:0.012604:0.006042:0.006658:0.012604:0.012508:0.007466:0.006523:0.005709:0.012604:0.006388
gen receptors (ER), progesterone recep-:@0.524242:0.514304:0.915151:0.514304:0.915151:0.498548:0.524242:0.498548:0.012950:0.012508:0.011738:0.008717:0.005711:0.012508:0.012450:0.012508:0.013123:0.006523:0.012604:0.005792:0.007466:0.008717:0.007100:0.010314:0.011680:0.007100:0.005330:0.008717:0.013123:0.005715:0.012604:0.012950:0.012508:0.007466:0.006523:0.012498:0.005713:0.012604:0.011738:0.012508:0.008717:0.005711:0.012508:0.012450:0.012508:0.013123:0.006388
tors (PR), HER2 neu expression, and Ki67.:@0.524242:0.530536:0.894404:0.530536:0.894404:0.514780:0.524242:0.514780:0.006523:0.012604:0.005792:0.007466:0.005330:0.007100:0.011392:0.011680:0.007100:0.005330:0.005330:0.013143:0.010314:0.011680:0.010660:0.005330:0.011738:0.012508:0.011699:0.005330:0.012508:0.009236:0.013123:0.005692:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.013143:0.011738:0.013181:0.005330:0.011372:0.003848:0.010660:0.010660:0.005330
HER2 neu overexpression is found in 20-:@0.542426:0.546768:0.915134:0.546768:0.915134:0.531012:0.542426:0.531012:0.013143:0.010314:0.011680:0.010660:0.007235:0.011738:0.012508:0.011699:0.007235:0.012604:0.010660:0.012508:0.005711:0.012508:0.009236:0.013123:0.005711:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.007235:0.003848:0.007466:0.007235:0.006042:0.012604:0.011699:0.011738:0.013181:0.007226:0.003848:0.011738:0.007235:0.010660:0.010660:0.006388
30% of all breast cancers, and portends a :@0.524242:0.563000:0.920495:0.563000:0.920495:0.547244:0.524242:0.547244:0.010660:0.010660:0.014913:0.005965:0.012604:0.006042:0.005952:0.013143:0.003848:0.003848:0.005965:0.013123:0.005717:0.012508:0.013143:0.007466:0.006523:0.005965:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.005950:0.013143:0.011738:0.013181:0.005965:0.013123:0.012604:0.005792:0.006523:0.012508:0.011738:0.013181:0.007466:0.005948:0.013143:0.005330
poorer prognosis with a propensity for dis-:@0.524242:0.579232:0.915145:0.579232:0.915145:0.563476:0.524242:0.563476:0.013123:0.012604:0.012604:0.005707:0.012508:0.005792:0.006254:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.006254:0.015990:0.003848:0.006523:0.011738:0.006254:0.013143:0.006254:0.013123:0.005717:0.012604:0.013123:0.012508:0.011738:0.007466:0.003848:0.006523:0.010314:0.006254:0.006042:0.012604:0.005792:0.006254:0.013181:0.003848:0.007466:0.006388
tant spread.:@0.524242:0.595465:0.637959:0.595465:0.637959:0.579709:0.524242:0.579709:0.006523:0.013143:0.011738:0.006523:0.005330:0.007466:0.013123:0.005709:0.012508:0.013143:0.013181:0.005330
The  diagnosis is made on  immunohis-:@0.542426:0.611697:0.915147:0.611697:0.915147:0.595941:0.542426:0.595941:0.008197:0.011738:0.012508:0.005330:0.005875:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.011218:0.003848:0.007466:0.011218:0.018049:0.013143:0.013181:0.012508:0.011218:0.012604:0.011738:0.005330:0.005879:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.011738:0.003848:0.007466:0.006388
tochemistry,  and an equivocal result is :@0.524242:0.627929:0.920468:0.627929:0.920468:0.612173:0.524242:0.612173:0.006523:0.012604:0.012450:0.011738:0.012508:0.018049:0.003848:0.007466:0.006523:0.005792:0.010314:0.005330:0.005330:0.007031:0.013143:0.011738:0.013181:0.012373:0.013143:0.011738:0.012373:0.012508:0.013123:0.011699:0.003848:0.010660:0.012604:0.012450:0.013143:0.003848:0.012373:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.012373:0.003848:0.007466:0.005330
confirmed by SISH and reported accord-:@0.524242:0.644161:0.915157:0.644161:0.915157:0.628405:0.524242:0.628405:0.012450:0.012604:0.011738:0.004686:0.004686:0.006313:0.018049:0.012508:0.013181:0.007739:0.013123:0.010314:0.007745:0.009583:0.004349:0.009583:0.013143:0.007745:0.013143:0.011738:0.013181:0.007741:0.005711:0.012508:0.013123:0.012604:0.005792:0.006523:0.012508:0.013181:0.007737:0.013143:0.012450:0.012450:0.012604:0.005673:0.013181:0.006388
ing the College of American Pathologists :@0.524242:0.660393:0.920495:0.660393:0.920495:0.644637:0.524242:0.644637:0.003848:0.011738:0.012950:0.007447:0.006523:0.011738:0.012508:0.007435:0.015644:0.012604:0.003848:0.003848:0.012508:0.012950:0.012508:0.007437:0.012604:0.006042:0.007437:0.014239:0.018049:0.012508:0.005792:0.003848:0.012450:0.013143:0.011738:0.007433:0.011392:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.007466:0.005330
(CAP).:@0.524242:0.676626:0.585048:0.676626:0.585048:0.660870:0.524242:0.660870:0.007100:0.015644:0.014239:0.011392:0.007100:0.005330
Immunohistochemistry is a surrogate for :@0.542426:0.692858:0.920485:0.692858:0.920485:0.677102:0.542426:0.677102:0.004349:0.018049:0.018049:0.011699:0.011738:0.012604:0.011738:0.003848:0.007466:0.006523:0.012604:0.012450:0.011738:0.012508:0.018049:0.003848:0.007466:0.006523:0.005792:0.010314:0.007014:0.003848:0.007466:0.007023:0.013143:0.007023:0.007466:0.011699:0.005792:0.005709:0.012604:0.012950:0.013143:0.006523:0.012508:0.007023:0.006042:0.012604:0.005792:0.005330
profiling  of  tumour  biology  which  is  best :@0.524242:0.709090:0.920483:0.709090:0.920483:0.693334:0.524242:0.693334:0.013123:0.005715:0.012604:0.004686:0.004686:0.003848:0.003848:0.011738:0.012950:0.005330:0.004118:0.012604:0.006042:0.005330:0.004118:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.004114:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.004126:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330:0.004122:0.003848:0.007466:0.005330:0.004131:0.013123:0.012508:0.007466:0.006523:0.005330
characterised  by tumour  micro-arrays, :@0.524242:0.725322:0.920485:0.725322:0.920485:0.709566:0.524242:0.709566:0.012450:0.011738:0.013143:0.005792:0.013143:0.012450:0.006523:0.012508:0.005792:0.003848:0.007466:0.012508:0.013181:0.005330:0.011513:0.013123:0.010314:0.016856:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.011505:0.018049:0.003848:0.012450:0.005715:0.012604:0.006388:0.013143:0.005792:0.005792:0.013143:0.010314:0.007466:0.005330:0.005330
which are not readily available.:@0.524242:0.741554:0.818685:0.741554:0.818685:0.725798:0.524242:0.725798:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330:0.013143:0.005711:0.012508:0.005330:0.011738:0.012604:0.006523:0.005330:0.005696:0.012508:0.013143:0.013181:0.003848:0.003848:0.010314:0.005330:0.013143:0.010660:0.013143:0.003848:0.003848:0.013143:0.013123:0.003848:0.012508:0.005330
Tumour  biology is divided into  luminal :@0.542426:0.757786:0.920470:0.757786:0.920470:0.742031:0.542426:0.742031:0.007310:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.005390:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.010314:0.010737:0.003848:0.007466:0.010737:0.013181:0.003848:0.010660:0.003848:0.013181:0.012508:0.013181:0.010737:0.003848:0.011738:0.006523:0.012604:0.005330:0.005396:0.003848:0.011699:0.018049:0.003848:0.011738:0.013143:0.003848:0.005330
A-like, luminal B-like, HER2-enriched,  and :@0.524242:0.774019:0.920472:0.774019:0.920472:0.758263:0.524242:0.758263:0.014239:0.006388:0.003848:0.003848:0.009660:0.012508:0.005330:0.009236:0.003848:0.011699:0.018049:0.003848:0.011738:0.013143:0.003848:0.009236:0.011045:0.006388:0.003848:0.003848:0.009660:0.012508:0.005330:0.009236:0.013143:0.010314:0.011680:0.010660:0.006388:0.012508:0.011738:0.005792:0.003848:0.012450:0.011738:0.012508:0.013181:0.005330:0.005330:0.003897:0.013143:0.011738:0.013181:0.005330
basal-like.:@0.524242:0.790251:0.616548:0.790251:0.616548:0.774495:0.524242:0.774495:0.013123:0.013143:0.007466:0.013143:0.003848:0.006388:0.003848:0.003848:0.009660:0.012508:0.005330
Luminal A cancers tend to be ER/PR-:@0.542426:0.806483:0.915151:0.806483:0.915151:0.790727:0.542426:0.790727:0.008890:0.011699:0.018049:0.003848:0.011738:0.013143:0.003848:0.010526:0.014239:0.010526:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.010526:0.006523:0.012508:0.011738:0.013181:0.010526:0.006523:0.012604:0.010526:0.013123:0.012508:0.010526:0.010314:0.011680:0.008409:0.011392:0.011680:0.006388
positive, HER2-negative, with a low Ki 67 of :@0.524242:0.822715:0.920501:0.822715:0.920501:0.806959:0.524242:0.806959:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330:0.004965:0.013143:0.010314:0.011680:0.010660:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.004965:0.015990:0.003848:0.006523:0.011738:0.004965:0.013143:0.004965:0.003848:0.012604:0.015990:0.004965:0.011372:0.003848:0.004965:0.010660:0.010660:0.004965:0.012604:0.006042:0.005330
less than or equal to 14%.:@0.524242:0.838947:0.758730:0.838947:0.758730:0.823191:0.524242:0.823191:0.003848:0.012508:0.007466:0.007466:0.005330:0.006523:0.011738:0.013143:0.011738:0.005330:0.012604:0.005792:0.005330:0.012508:0.013123:0.011699:0.013143:0.003848:0.005330:0.006523:0.012604:0.005330:0.010660:0.010660:0.014913:0.005330
Luminal B-like cancers  are  ER-positive, :@0.542426:0.855180:0.920479:0.855180:0.920479:0.839424:0.542426:0.839424:0.008890:0.011699:0.018049:0.003848:0.011738:0.013143:0.003848:0.010757:0.011045:0.006388:0.003848:0.003848:0.009660:0.012508:0.010757:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.005415:0.013143:0.005715:0.012508:0.005330:0.005417:0.010314:0.011680:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330:0.005330
PR-negative, HER2-negative, with a high Ki :@0.524242:0.871412:0.920493:0.871412:0.920493:0.855656:0.524242:0.855656:0.011392:0.011680:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.004814:0.013143:0.010314:0.011680:0.010660:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.004830:0.015990:0.003848:0.006523:0.011738:0.004830:0.013143:0.004830:0.011738:0.003848:0.012950:0.011738:0.004818:0.011372:0.003848:0.005330
67 of >14%.:@0.524242:0.887644:0.628093:0.887644:0.628093:0.871888:0.524242:0.871888:0.010660:0.010660:0.005330:0.012604:0.006042:0.005330:0.011661:0.010660:0.010660:0.014913:0.005330
HER2-enriched are HER2-overexpressing, :@0.542426:0.903876:0.920485:0.903876:0.920485:0.888120:0.542426:0.888120:0.013143:0.010314:0.011680:0.010660:0.006388:0.012508:0.011738:0.005792:0.003848:0.012450:0.011738:0.012508:0.013181:0.004926:0.013143:0.005715:0.012508:0.004926:0.013143:0.010314:0.011680:0.010660:0.006388:0.012604:0.010660:0.012508:0.005719:0.012508:0.009236:0.013123:0.005715:0.012508:0.007466:0.007466:0.003848:0.011738:0.012950:0.005330:0.005330
and the basal-like  cancers include, but :@0.524242:0.920108:0.920485:0.920108:0.920485:0.904352:0.524242:0.904352:0.013143:0.011738:0.013181:0.010718:0.006523:0.011738:0.012508:0.010718:0.013123:0.013143:0.007466:0.013143:0.003848:0.006388:0.003848:0.003848:0.009660:0.012508:0.005330:0.005411:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.010718:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330:0.010718:0.013123:0.011699:0.006523:0.005330
are  not  limited  to,  triple-negative breast :@0.524242:0.936341:0.920485:0.936341:0.920485:0.920585:0.524242:0.920585:0.013143:0.005715:0.012508:0.005330:0.004276:0.011738:0.012604:0.006514:0.005330:0.004278:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.005330:0.004278:0.006523:0.012604:0.005330:0.005330:0.004270:0.006523:0.005792:0.003848:0.013123:0.003848:0.012508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.009621:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.005330
Breast Cancer:@0.084848:0.111850:0.378188:0.111850:0.378188:0.076219:0.084848:0.076219:0.024801:0.013683:0.027367:0.028222:0.018815:0.012828:0.011973:0.033354:0.028222:0.025657:0.027367:0.027367:0.013683